Reddit Thread Reveals ADHD Stigma in Indian Workplaces

A product manager’s post about losing their job to ADHD drew hundreds of responses from professionals across India. Read together, they document not one person’s crisis, but a structural failure hiding in plain sight.

Source: r/ProductManagement_IN Reddit thread, u/Complex_Spirit5914 · Statistics: Social Psychiatry and Psychiatric Epidemiology (2025), WHO World Mental Health Survey, National Mental Health Survey India 2015–16

The post was not intended to go viral. It was written by someone who had just lost their job and needed to say it out loud somewhere. “I got laid off,” wrote u/Complex_Spirit5914 on a subreddit for Indian product managers. “I was not surprised.”

What followed in the comments was something rarer than viral content — it was recognition. Comment after comment arrived from people who knew exactly what the OP meant. Not the layoff. The years before it.

“God, this is so me. I’ve been lucky enough to not get exposed. But the constant pressure to perform like a normal person is insane… I like myself half the day and absolutely loathe twice that amount in the other half.”

u/kartik195, commenting on the thread

That comment, and dozens like it, transforms the original post from a personal story into something more useful: a window into what adult ADHD actually looks like inside India’s tech and product management ecosystem — and what the numbers behind it reveal.

The numbers behind the thread

Adult ADHD in India is simultaneously widespread and almost entirely unaddressed. A 2025 systematic review published in Social Psychiatry and Psychiatric Epidemiology found adult ADHD prevalence ranging from 5.48% to 25.7% across Indian populations — with a Delhi-NCR cross-sectional study screening 14% of young adults positive using the ASRS diagnostic tool. Globally, a 2024 meta-analysis estimates persistent adult ADHD at 6.76%, affecting an estimated 366 million adults worldwide.

Infographic showing four ADHD-related statistics in India. It reports an estimated adult ADHD prevalence of 5.5–25.7%, an 84.5% mental health treatment gap, 0.75 psychiatrists per 100,000 people compared with the WHO minimum of 3, and that 17.4% of adults with ADHD have been fired from a job versus 3.7% of adults without ADHD.
Research suggests that adult ADHD may be common in India, but diagnosis and support remain limited. The infographic summarizes the estimated prevalence of adult ADHD, the national treatment gap, the shortage of psychiatrists and the greater risk of job loss reported by adults with ADHD.

The treatment gap is the number that matters most here. India reports an 84.5% gap between people with mental health conditions and those receiving any formal care. For ADHD specifically — a condition that carries particular stigma, requires specialist diagnosis, and in many cases involves controlled medications facing regulatory barriers — the gap is likely wider still.

What masking looks like from the inside

The OP’s story follows a pattern documented across the thread with striking consistency. High performance for years, sustained by creativity and compensatory effort. Then a slow accumulation of structural pressure the masking strategies can no longer absorb. Then collapse.

“I always literally live in fear that I may be exposed anytime, I am just riding my creativity, when it stops I am done. I am an undergrad currently, I resigned from an internship just cos I lost interest, I am joining next as PM intern, I don’t know how I will even live.”

u/Fanaticseva

“My manager is always surprised to know how I got the thing done that was supposed to take way more time — but I can’t tell him it’s the hyperfocus phase I can’t get into at will. And other times, he asks me why I’m never seen at my desk… I’m either in the game room or talking to people in other teams.”

u/kartik195

The WHO World Mental Health Survey found that adults with ADHD lose an average of 21.7 workdays each year because they get less done, and another 13.6 days because the quality of their work declines, in addition to 8.4 days of actual absence. Across the 10 countries studied, this translated into an estimated 143.8 million lost workdays annually. (PMC)

Studies also suggest that adults with ADHD may earn substantially less over their careers. In one US-based analysis, self-reported ADHD was associated with earnings that were approximately one-third lower than those of adults without ADHD. (tandfonline.com)

The medication question the thread could not resolve

The most contested territory in the thread was medication. The OP’s rejection of it — framing it as a “fraud industry” that would “numb creativity” — drew both pushback and sympathy in roughly equal measure. What emerged was not a debate about whether medication works, but about whether it is accessible, trustworthy, or safe to pursue in an Indian context.

“The last time I tried medication, I was depressed, couldn’t feel a thing and was just numb. I decided I am better off without it. This was 3 years back. I am afraid if I start it again it’ll blunt my thinking.”

u/Complex_Spirit5914, OP — in reply to a comment urging medication

“I got diagnosed last year and started meds. Has changed my life. I take it as needed — you can skip on days you gotta be creative.”

u/Dheesaur


“I can’t find methylphenidate in the pharmacy in Bangalore.”

u/Significant-Zone6564

The three barriers the thread documents simultaneously

1 Access — regulatory and geographic

Amphetamine salts, the most widely prescribed ADHD stimulants in the US and Europe, are prohibited in India under the NDPS Act 1985. They are not available in Indian pharmacies in any form. Methylphenidate — the only legal stimulant option — is a Schedule X controlled substance that requires an in-person specialist prescription, written with full patient documentation. It cannot be initiated through telemedicine under India’s 2020 Telepsychiatry Operational Guidelines. The commenter who could not find methylphenidate in a Bangalore pharmacy was not merely describing a stock issue. Schedule X availability is uneven across cities and often minimal outside them. India has approximately 0.75 psychiatrists per 100,000 people against a WHO benchmark of 3 per 100,000, with most concentrated in urban centres. Getting the prescription requires finding a prescriber first.

Sources: NDPS Act 1985; Drugs and Cosmetics Rules, Schedule X; Telepsychiatry Operational Guidelines 2020; Indian Journal of Psychiatry; WHO mental health data.

2 Stigma — documented and specific to the Indian workplace

A 2024 study in BMC Public Health examining workplace mental health disclosure in India found that employees frequently conceal diagnoses from managers because they fear being sidelined from client-facing roles, excluded from decision-making, or judged less competent. One participant described delaying disclosure of an adult ADHD diagnosis for months out of concern that it would affect client access. Counsellors also reported that employees doubted confidentiality even in formal HR processes and worried that information would be escalated to supervisors. In the Reddit thread, this pattern appears repeatedly and without prompting. The fear is not abstract. It is an everyday workplace calculation.

Source: Thakur et al., BMC Public Health (2024), exploratory study on detection and disclosure of workplace mental health challenges in India.

3 Trust — eroded by undertreated side effects and thin follow-up infrastructure

The original poster’s rejection of medication is not simply ideological resistance. It can be read as the downstream consequence of a prior treatment episode in which side effects such as depression and emotional blunting were not adequately managed, and follow-up care was insufficient to refine dose or formulation. That pattern is plausible in a system with limited specialist follow-up. Methylphenidate adherence in India is higher when symptom improvement is clear, but side effects without close clinical review predict dropout. Non-stimulant options such as atomoxetine are pharmacologically distinct and may be initiated through telepsychiatry, yet many patients encounter them later or not at all. The result is not just delayed treatment. It is diminished trust in treatment itself.

Sources: Rajkumar (2025) on ADHD prescribing trends in India; Telepsychiatry Operational Guidelines 2020; international ADHD medication access literature.

Amphetamine salts — including Adderall and similar formulations widely prescribed for ADHD in the United States — are prohibited in India under the NDPS Act 1985, which classifies amphetamines as psychotropic substances subject to strict controls, with possession outside narrow medical and scientific exceptions constituting a criminal offence. They are not available in Indian pharmacies in any form.

Methylphenidate — the other major stimulant class used in ADHD treatment globally — is legal in India but tightly regulated as a Schedule X controlled substance, requiring a specialist prescription written on tamper-proof prescription pads with full patient documentation. It cannot be prescribed via telemedicine under India’s 2020 Telepsychiatry Operational Guidelines, meaning an in-person psychiatrist visit is mandatory before any stimulant treatment can begin. Non-stimulant options such as atomoxetine are more accessible and can be initiated via teleconsult, but stimulants — for patients who need them — sit behind a regulatory and physical access barrier that much of India’s population simply cannot clear. The commenter who could not find methylphenidate in a Bangalore pharmacy was not describing a stock problem. They were describing a system.

The person who found a way through — without medication

Not every voice in the thread is one of crisis. One commenter, u/xico_punch_loner, describes a different path: “I took [medication] for a year and then I figured out exercising and keeping gut pure clean — no junk since 2 years — and deleting Instagram has worked wonders for me.” The comment is not prescriptive. It is simply one data point in a thread full of people trying to find whatever works within whatever they have access to.

The research context for this is real. Exercise has a documented evidence base in ADHD symptom management — several controlled trials show aerobic exercise produces measurable improvements in attention, working memory, and impulse control. Reducing ultra-processed food and social media use reduces dopaminergic overstimulation. These are not replacements for clinical care. But in a country where clinical care reaches fewer than one in five people with a mental health condition, they are not nothing either.

What the OP asked at the end — and why it matters

Near the end of the thread, u/Complex_Spirit5914 posted two questions that cut to the heart of what this community was actually trying to solve. The first: “What is the ONE THING that is simple but if I stay consistent, I can kick ADHD in the butt?” The second: “How can I use something like Claude etc to automate things for me that can take care of my symptoms?”

These are not the questions of someone who has given up. They are the questions of someone actively engineering around a system — healthcare, workplace, self — that was not built for them. The impulse to use AI tools as ADHD scaffolding is already widely documented in neurodivergent communities globally. External structure, task decomposition, deadline reminders, automated summaries of meetings — these are legitimate compensatory tools, not workarounds. They are what reasonable workplace accommodations look like when the workplace itself does not offer them.

What India’s workplaces are not yet doing

Research on workplace accommodations for ADHD suggests that relatively simple adjustments can substantially reduce the productivity and retention gap faced by affected employees. The most consistently supported measures are also among the least expensive: written rather than purely verbal instructions, flexible scheduling, protected uninterrupted work time, quieter work environments, and evaluating employees by output rather than physical presence. India’s technology sector is not structurally incompatible with these practices; many are already routine in remote-first and product-led companies. What is often missing is explicit recognition that neurodivergent employees exist in significant numbers, that their difficulties are neurologic rather than motivational, and that the cost of failing to accommodate them is measurable. Between 2012 and 2030, mental health conditions across all diagnoses are projected to cost India approximately US$1.03 trillion in lost productivity and economic output. ADHD is unlikely to account for all of that burden, but given its high prevalence and strong association with lower earnings, job loss and reduced work performance, it is likely to be a meaningful contributor. (Press Information Bureau)

The thread ends, as these threads do, with encouragement. “I know I am a champion,” the OP writes in their final reply. “I’ll accept everything but defeat even if it means fighting my own brain. I’ll use it in ways this world can’t fathom.”

That is a remarkable thing to write after a job loss. It is also, in the context of what India currently offers people in this situation, a sentence that should make employers, policymakers, and clinicians uncomfortable. Because the system is asking individuals to be champions. It is not doing much to make that easier.

Sources and Further Reading

  • Primary source: Reddit thread on r/ProductManagement_IN by u/Complex_Spirit5914, April 2026.
  • Adult ADHD prevalence in India: Mishra S, et al. Social Psychiatry and Psychiatric Epidemiology. 2025.
  • Work productivity and lost workdays: Kessler RC, et al. WHO World Mental Health Survey Initiative.
  • Mental health treatment gap in India: National Mental Health Survey of India 2015–16.
  • Job loss and occupational impact: Murphy KR, Barkley RA. Adult ADHD and occupational functioning.
  • Economic context and India-specific productivity burden: Think Global Health and Observer Research Foundation analyses based on WHO and Indian mental health data.
Medical disclaimer: This article is for informational purposes only and is not a substitute for medical advice, diagnosis or treatment. If you think you may have ADHD or another mental health condition, contact a qualified mental health professional. Tele MANAS: 14416 — free, confidential, available 24×7 in 20+ languages.

6 Replies to “Reddit Thread Reveals ADHD Stigma in Indian Workplaces

  1. Thanks for sharing this. This article highlights very important gaps which needs to be addressed. Acceptance and awareness at workplace and among the community, reformation of the current policies, pharmaco therapy are some of the possible important actions required.

    1. Thank you. I agree, hopefully this instance draws more attention from employers, policymakers and regulators to the need for better awareness, clearer workplace protections and easier access to care.

  2. An insightful review. Recently going through something like this with my brother gonna share this with him . 💓

  3. Great post—beautifully captures how workplace culture often misunderstands and fails to support people with ADHD.

Leave a Reply

Your email address will not be published. Required fields are marked *